amikacin has been researched along with Diabetic Feet in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 2 (50.00) | 2.80 |
Authors | Studies |
---|---|
Agoons, BB; Etoga, MCE; Jingi, AM; Mbanya, JC; Mekobe, FM; Ngassam, E; Sobngwi, E; Yefou, MD | 1 |
Fang, W; Liu, W; Song, L; Sun, W; Wang, C | 1 |
El-Naggar, MY; Gohar, YM; Sorour, MA; Waheeb, MG | 1 |
Al-Ebous, AD; Al-Jahmi, M; Al-Zuriqat, AN; Hiasat, B; Sarayrah, M | 1 |
1 trial(s) available for amikacin and Diabetic Feet
Article | Year |
---|---|
Management of diabetic foot in a Jordanian hospital.
Topics: Amikacin; Amputation, Surgical; Anti-Bacterial Agents; Ceftazidime; Chemotherapy, Adjuvant; Debridement; Diabetic Foot; Drug Combinations; Drug Monitoring; Humans; Imipenem; Kidney Diseases; Length of Stay; Lincomycin; Metronidazole; Patient Selection; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; Severity of Illness Index; Treatment Outcome; Wound Healing; Wound Infection | 2005 |
3 other study(ies) available for amikacin and Diabetic Feet
Article | Year |
---|---|
Bacterial profile of diabetic foot infections and antibiotic susceptibility in a specialized diabetes centre in Cameroon.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cameroon; Communicable Diseases; Diabetes Mellitus, Type 2; Diabetic Foot; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies | 2022 |
Distribution of microbes and antimicrobial susceptibility in patients with diabetic foot infections in South China.
Topics: Amikacin; Anti-Bacterial Agents; Coinfection; Diabetes Mellitus; Diabetic Foot; Ertapenem; Gram-Negative Bacteria; Humans; Meropenem; Retrospective Studies; Tigecycline | 2023 |
Hydrogel Dressing with a Nano-Formula against Methicillin-Resistant Staphylococcus aureus and Pseudomonas aeruginosa Diabetic Foot Bacteria.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Artemia; Bacteria; Bandages, Hydrocolloid; Chitosan; Coinfection; Diabetes Mellitus, Experimental; Diabetic Foot; Drug Resistance, Multiple, Bacterial; Metal Nanoparticles; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Rats; Silver; Staphylococcus aureus; Wound Healing | 2016 |